491 results on '"Olteanu, Horatiu"'
Search Results
2. Dual T-cell constant β chain (TRBC)1 and TRBC2 staining for the identification of T-cell neoplasms by flow cytometry
3. PCNEO, a New Proficiency Testing Program for Flow Cytometric Analysis of Plasma Cell Neoplasms From the College of American Pathologists Diagnostic Immunology and Flow Cytometry Committee
4. Computational Flow Cytometry Accurately Identifies Sezary Cells Based on Simplified Aberrancy and Clonality Features
5. Venous and arterial thrombosis in patients with VEXAS syndrome
6. Abnormal karyotype is an independent predictor of inferior survival in Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
7. Utility of flow cytometry screening before MRD testing in multiple myeloma
8. Establishing NK-Cell Receptor Restriction by Flow Cytometry and Detecting Potential NK-Cell Clones of Uncertain Significance
9. Spectrum of clonal hematopoiesis in VEXAS syndrome
10. Identification of EWSR1 rearrangements in patients with immature hematopoietic neoplasms: A case series and review of literature
11. Allogeneic haematopoietic cell transplantation for extranodal natural killer/T‐cell lymphoma, nasal type: a CIBMTR analysis
12. Clinical utility of next generation sequencing to detect IGH/IL3 rearrangements [t(5;14)(q31.1;q32.1)] in B-lymphoblastic leukemia/lymphoma
13. CD2 and CD7 are sensitive flow cytometry screening markers for T-lineage acute leukemia(s): a study of 465 acute leukemia cases
14. Allogeneic Hematopoietic Cell Transplantation for Aggressive NK Cell Leukemia. A Center for International Blood and Marrow Transplant Research Analysis
15. Utility of TRBC1 Expression in the Diagnosis of Peripheral Blood Involvement by Cutaneous T-Cell Lymphoma
16. Lymphoblastic Leukemia/Lymphoma
17. Erythroblastic sarcoma transformation from a chronic myeloid neoplasm with FGFR1 rearrangement presenting as a pleural effusion: a case report
18. Increased CD200 expression in post-transplant lymphoproliferative disorders correlates with an increased frequency of FoxP3(+) regulatory T cells
19. T-cell clones of uncertain significance are highly prevalent and show close resemblance to T-cell large granular lymphocytic leukemia. Implications for laboratory diagnostics
20. Detection of cryptic CCND1 rearrangements in mantle cell lymphoma by next generation sequencing
21. Prevalence and spectrum of T-cell lymphoproliferative disorders in patients with Hypereosinophilia: A reference laboratory experience
22. Comprehensive morphologic characterization of bone marrow biopsy findings in a large cohort of patients with VEXAS syndrome: A single-institution longitudinal study of 111 bone marrow samples from 52 patients
23. Pilot Prospective Study of Reduced Intensity Conditioning Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Vexas Syndrome
24. FDA IDE validation of multiple myeloma MRD test by flow cytometry.
25. Molecular markers demonstrate diagnostic and prognostic value in the evaluation of myelodysplastic syndromes in cytopenia patients
26. Multicenter Analysis of Advanced Stage Grade 3A Follicular Lymphoma Outcomes by Frontline Treatment Regimen
27. Dual T-cell constant β chain (TRBC)1 and TRBC2 staining for the identification of T-cell neoplasms by flow cytometry
28. VEXAS syndrome: Clinical, hematologic features and a practical approach to diagnosis and management
29. Hodgkin Lymphoma, Mediastinal
30. Castleman Disease, Mediastinal
31. B-Cell Lymphoma, Mediastinal, Diffuse, and Large
32. Pleomorphic Lymphoma, Mediastinal
33. Mediastinal Mucosa-Associated Lymphoid Tissue Lymphoma
34. Mediastinal Anaplastic Large-Cell Lymphoma
35. Efficacy of High-Dose Therapy and Autologous Hematopoietic Cell Transplantation in Gray Zone Lymphoma: A US Multicenter Collaborative Study
36. PCNEO, a New Proficiency Testing Program for Flow Cytometric Analysis of Plasma Cell Neoplasms From the College of American Pathologists Diagnostic Immunology and Flow Cytometry Committee
37. Superior detection rate of plasma cell FISH using FACS-FISH
38. Evaluation of CD43 expression in non-hematopoietic malignancies
39. VEXAS syndrome: Clinical, hematologic features and a practical approach to diagnosis and management.
40. Lymphoblastic Leukemia/Lymphoma
41. Targeted testing of bone marrow specimens with cytoplasmic vacuolization to identify previously undiagnosed cases of VEXAS syndrome
42. Proliferation centers in bone marrows involved by chronic lymphocytic leukemia/small lymphocytic lymphoma: a clinicopathologic analysis
43. Role of Flow Cytometry in the Diagnosis and Prognosis of Plasma Cell Myeloma
44. Superior detection rate of plasma cell FISH using FACS-FISH.
45. ANCA ‐associated vasculitis and VEXAS syndrome: a comment on the article by Muratore et al.
46. Improved semiautomated detection of TRBC-restricted Sézary cells unveils a spectrum of clonal cluster immunophenotypes
47. Reduced intensity conditioning allogeneic hematopoietic stem cell transplantation in VEXAS syndrome: Data from a prospective series of patients
48. DNMT3A/TET2 Mutant Clonal Hematopoiesis in Vexas Syndrome Results in DNA Hypomethylation and Transcriptional Activation of WT1 and MPL Oncogenic Pathways
49. Monocytopenia As an Adverse Prognosticator in Vexas Syndrome
50. Clonal Hematopoiesis in Vexas Syndrome
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.